Show simple item record
Author | dc.contributor.author | Troncoso Cotal, Rodrigo | |
Author | dc.contributor.author | Moraga, Francisco | |
Author | dc.contributor.author | Chiong Lay, Mario | |
Author | dc.contributor.author | Roldán, Juan | |
Author | dc.contributor.author | Bravo, Roberto | |
Author | dc.contributor.author | Valenzuela, Rodrigo | |
Author | dc.contributor.author | Díaz Araya, Guillermo | |
Author | dc.contributor.author | Del Campo, Andrea | |
Author | dc.contributor.author | Sanhueza, Carlos | |
Author | dc.contributor.author | Rodriguez, Andrea | |
Author | dc.contributor.author | Vukasovic, José Luis | |
Author | dc.contributor.author | Mellado, Rosemarie | |
Author | dc.contributor.author | Greig, Douglas | |
Author | dc.contributor.author | Castro, Pablo F. | |
Author | dc.contributor.author | Lavandero González, Sergio | |
Admission date | dc.date.accessioned | 2019-03-11T12:57:28Z | |
Available date | dc.date.available | 2019-03-11T12:57:28Z | |
Publication date | dc.date.issued | 2009 | |
Cita de ítem | dc.identifier.citation | Basic and Clinical Pharmacology and Toxicology, Volumen 104, Issue 5, 2018, Pages 374-378 | |
Identifier | dc.identifier.issn | 17427835 | |
Identifier | dc.identifier.issn | 17427843 | |
Identifier | dc.identifier.other | 10.1111/j.1742-7843.2008.00370.x | |
Identifier | dc.identifier.uri | https://repositorio.uchile.cl/handle/2250/164741 | |
Abstract | dc.description.abstract | We investigated the clinical response of chronic heart failure patients with β2-adrenergic receptor Gln27→Glu polymorphism treated for 6 months with carvedilol, a α/β-antagonist with antioxidant properties. The 6-min. walk test, the left ventricular ejection fraction, heart rate, plasma norepinephrine and malondialdehyde, a stress oxidative marker, concentrations were evaluated at baseline and after treatment for 6 months with carvedilol in 33 stable chronic heart failure patients with the Gln27→Gluβ2-adrenergic receptor polymorphism. Carvedilol significantly increased the left ventricular ejection fraction, while decreasing the heart rate and malondialdehyde plasma concentrations in chronic heart failure patients with the Glu 27β2-adrenergic receptor allele. There were however, no significant changes in patients with the Gln27β2- adrenergic receptor variant. © 2009 Nordic Pharmacological Society. | |
Lenguage | dc.language.iso | en | |
Type of license | dc.rights | Attribution-NonCommercial-NoDerivs 3.0 Chile | |
Link to License | dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/cl/ | |
Source | dc.source | Basic and Clinical Pharmacology and Toxicology | |
Keywords | dc.subject | Toxicology | |
Keywords | dc.subject | Pharmacology | |
Título | dc.title | Gln27→Gluβ2-adrenergic receptor polymorphism in heart failure patients: Differential clinical and oxidative response to carvedilol | |
Document type | dc.type | Artículo de revista | |
Cataloguer | uchile.catalogador | SCOPUS | |
Indexation | uchile.index | Artículo de publicación SCOPUS | |
uchile.cosecha | uchile.cosecha | SI | |
Files in this item
- Name:
- item_64549105750.pdf
- Size:
- 2.356Kb
- Format:
- PDF
This item appears in the following Collection(s)
Show simple item record
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile